Clinical Trial Update: Evaluation of Food Effect on Pharmacokinetics of Vismodegib [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated how food affects the pharmacokinetics of vismodegib in cancer patients. Results were completed and posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Malignant Neoplasm | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-15